These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 239123)

  • 21. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
    Kato T; Katsuyama M; Karai N; Nakamura M; Katsube J
    Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation by alpha-methyltyrosine of the suppression of food-reinforced lever-pressing behaviour induced by antipsychotic drugs.
    Ahlenius S; Engel J
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):115-25. PubMed ID: 13605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the locomotor activity of mice as measured by an Animex and photoresis to actometer.
    Maj J; Durek B; Palider W
    J Pharm Pharmacol; 1971 Dec; 23(12):979-81. PubMed ID: 4402032
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of clonidine on locomotor activity in mice.
    Maj J; Sowińska H; Baran L; Kapturkiewicz Z
    Life Sci I; 1972 May; 11(10):483-91. PubMed ID: 4676386
    [No Abstract]   [Full Text] [Related]  

  • 25. Behavioral and electrophysiological effects of phenylethanolamine and 2-phenylethylamine.
    Sabelli HC; Vazquez AJ; Flavin D
    Psychopharmacologia; 1975 May; 42(2):117-25. PubMed ID: 1161972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of substance P on the behavioral changes induced by haloperidol in rats.
    Jolicoeur FB; Rondeau DB; Belanger F; Fouriezos G; Barbeau A
    Peptides; 1980; 1(1):103-7. PubMed ID: 6165976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of L-dopa and (+)-amphetamine on the locomotor activity after pimozide and phenoxybenzamine.
    Maj J; Sowinska H; Kapturkiewicz Z; Sarnak J
    J Pharm Pharmacol; 1972 May; 24(5):412-4. PubMed ID: 4403816
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacologic studies with 7-benzyl-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid.
    Aceto MD; Harris LS; Lesher GY; Pearl J; Brown TG
    J Pharmacol Exp Ther; 1967 Nov; 158(2):286-93. PubMed ID: 4383638
    [No Abstract]   [Full Text] [Related]  

  • 29. Brain monoamines and the high pressure neurological syndrome.
    Koblin DD; Little HJ; Green AR; Daniels S; Smith EB; Paton WD
    Neuropharmacology; 1980 Nov; 19(11):1031-8. PubMed ID: 6449674
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological evidence for the involvement of GABA-ergic system in the locomotor stimulation produced in mice by 1,3-dimethyl-5-aminoadamantane (D-145).
    Menon MK; Clark WG
    Neuropharmacology; 1978 Dec; 17(12):1049-52. PubMed ID: 745691
    [No Abstract]   [Full Text] [Related]  

  • 31. Sensitization by caffeine of central catecholamine receptors.
    Waldeck B
    J Neural Transm; 1973; 34(1):61-72. PubMed ID: 4714594
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological studies on tetrabenazine-induced excited behaviour of rats pretreated with amphetamine or nialamide.
    Scheel-Krüger J; Jonas W
    Arch Int Pharmacodyn Ther; 1973 Nov; 206(1):47-65. PubMed ID: 4798103
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of apomorphine on motility in rats.
    Maj J; Grabowska M; Gajda L
    Eur J Pharmacol; 1972 Feb; 17(2):208-14. PubMed ID: 5026397
    [No Abstract]   [Full Text] [Related]  

  • 35. A mode of action of morphine on a quickly learned conditioned suppression in mice.
    Kameyama T; Nagasaka M
    J Pharmacobiodyn; 1984 Mar; 7(3):151-5. PubMed ID: 6235360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The involvement of the catecholaminergic system in physostigmine-induced hyperactivity in rats.
    Egbe PC
    Arzneimittelforschung; 1982; 32(1):27-9. PubMed ID: 6460507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of amantadine on motor activity and catalepsy in rats.
    Maj J; Sowińska H; Baran L
    Psychopharmacologia; 1972; 24(2):296-307. PubMed ID: 5064006
    [No Abstract]   [Full Text] [Related]  

  • 38. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
    Dolphin A; Jenner P; Marsden CD
    J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
    [No Abstract]   [Full Text] [Related]  

  • 39. Disulfiram and the drug-induced effects on motility.
    Maj J; Przegaliński E; Wielosz M
    J Pharm Pharmacol; 1968 Mar; 20(3):247-8. PubMed ID: 4385060
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of LSD on locomotor activity in reserpinized mice.
    Grabowska M; Antikiewicz L; Michaluk J
    Pol J Pharmacol Pharm; 1974; 26(5):499-504. PubMed ID: 4427810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.